Through the 90-day period concluding December 12, 2025, Travere Therapeutics's top three insider stakeholders include Chief Executive Officer Eric M Dube (419.17K shares), Chief Commercial Officer Peter Heerma (117.99K shares), Chief Research Officer William E. Rote (100.24K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Eric M Dube | Chief Executive Officer | 419,173 | 30 Oct, 2025 |
| Steve Aselage | 166,419 | 12 May, 2022 | |
| Peter Heerma | Chief Commercial Officer | 117,993 | 04 Nov, 2025 |
| William E. Rote | Chief Research Officer | 100,241 | 05 May, 2025 |
| Christopher R. Cline | Chief Financial Officer | 92,083 | 03 Dec, 2025 |
| Elizabeth E Reed | Chief Legal Officer And Gc | 89,878 | 24 Sep, 2025 |
| Jula Inrig | Chief Medical Officer | 88,787 | 02 Jul, 2025 |
| Jeffrey A Meckler | 87,500 | 16 May, 2025 | |
| Gary A Lyons | 57,500 | 16 May, 2025 | |
| Timothy Coughlin | 55,500 | 04 Nov, 2025 | |
| Sandra Calvin | SVP And Chief Accounting Officer | 48,545 | 06 Nov, 2025 |
| Noah L. Rosenberg | Chief Medical Officer | 47,614 | 17 Aug, 2021 |
| Roy D. Baynes | 37,500 | 16 May, 2025 | |
| Laura Clague | Chief Financial Officer | 35,655 | 12 May, 2022 |
| Ron Squarer | 35,375 | 16 May, 2025 | |
| John A Orwin | 35,375 | 16 May, 2025 | |
| Sandra Poole | 30,000 | 16 May, 2025 | |
| Suzanne Louise Bruhn | 28,750 | 16 May, 2025 | |
| Brinkley Ruth Williams | 25,750 | 16 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Dec, 2025 | Christopher R. Cline | Common Stock | A | 20,000 | $16.23 | 112,083 | D | M |
| 01 Dec, 2025 | Christopher R. Cline | Common Stock | D | 20,000 | $35.01 | 92,083 | D | S |
| 04 Nov, 2025 | Sandra Calvin | Common Stock | A | 10,000 | $25.25 | 64,410 | D | M |
| 04 Nov, 2025 | Sandra Calvin | Common Stock | A | 17,500 | $26.88 | 81,910 | D | M |
| 04 Nov, 2025 | Sandra Calvin | Common Stock | A | 15,000 | $27.50 | 96,910 | D | M |
| 04 Nov, 2025 | Sandra Calvin | Common Stock | A | 12,500 | $22.40 | 109,410 | D | M |
| 04 Nov, 2025 | Sandra Calvin | Common Stock | A | 6,250 | $8.93 | 115,660 | D | M |
| 04 Nov, 2025 | Sandra Calvin | Common Stock | D | 67,115 | $36.00 | 48,545 | D | S |
| 31 Oct, 2025 | Peter Heerma | Common Stock | D | 5,591 | $35.00 | 119,071 | D | S |
| 31 Oct, 2025 | Timothy Coughlin | Common Stock | A | 8,000 | $16.33 | 63,500 | D | M |
| 03 Nov, 2025 | Peter Heerma | Common Stock | D | 1,078 | $0.00 | 117,993 | D | G |
| 31 Oct, 2025 | Timothy Coughlin | Common Stock | A | 10,000 | $17.44 | 73,500 | D | M |
| 31 Oct, 2025 | Timothy Coughlin | Common Stock | D | 18,000 | $35.03 | 55,500 | D | S |
| 28 Oct, 2025 | Peter Heerma | Common Stock | D | 2,662 | $30.00 | 124,662 | D | S |
| 28 Oct, 2025 | Eric M Dube | Common Stock | A | 92,872 | $15.46 | 512,045 | D | M |
| 28 Oct, 2025 | Eric M Dube | Common Stock | D | 92,872 | $30.38 | 419,173 | D | S |
| 29 Oct, 2025 | Eric M Dube | Common Stock | A | 27,128 | $15.46 | 446,301 | D | M |
| 29 Oct, 2025 | Eric M Dube | Common Stock | D | 27,128 | $30.12 | 419,173 | D | S |
| 23 Sep, 2025 | Peter Heerma | Common Stock | D | 891 | $0.00 | 127,324 | D | G |
| 22 Sep, 2025 | Elizabeth E Reed | - | - | 99,878 | D |